The China Study - Complete References

Chapter 9

1. Mackay IR. "Tolerance and immunity." Brit. Med. Journ. 321 (2000): 93–96.

2. Jacobson DL, Gange SJ, Rose NR, et al. "Short analytical review. Epidemiology and estimated population burden of selected autoimmune diseases in the United States." Clin. Immunol. Immunopath.84 (1997): 223–243.

3. Davidson A, and Diamond B. "Autoimmune diseases." New Engl. J. Med. 345 (2001): 340–350.

4. Aranda R, Sydora BC, McAllister PL, et al. "Analysis of intestinal lymphocytes in mousecolitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients." J. Immunol. 158(1997): 3464–3473.

5. Folgar S, Gatto EM, Raina G, et al. "Parkinsonism as a manifestation of multiple sclerosis." Movement Disorders 18 (2003): 108–113.

6. Cantorna MT. "Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence?" Proc. Soc. Exp. Biol. Med. 223 (2000): 230–233.

7. DeLuca HF, and Cantorna MT. "Vitamin D: its role and uses in immunology." FASEB J. 15(2001): 2579–2585.

8. Winer S, Astsaturov I, Cheung RK, et al. "T cells of multiple sclerosis patients target acommon environmental peptide that causes encephalitis in mice." J. Immunol. 166 (2001):4751–4756.

9. Davenport CB. "Multiple sclerosis from the standpoint of geographic distribution and race."Arch. Neurol. Pschiatry 8 (1922): 51–58.

10. Alter M, Yamoor M, and Harshe M. "Multiple sclerosis and nutrition." Arch. Neurol. 31(1974): 267–272.

11. Carroll M. "Innate immunity in the etiopathology of autoimmunity." Nature Immunol. 2(2001): 1089–1090.

12. Karjalainen J, Martin JM, Knip M, et al. "A bovine albumin peptide as a possible trigger of insulin-dependent Diabetes Mellitus." New Engl. Journ. Med. 327 (1992): 302–307.

13. Akerblom HK, and Knip M. "Putative environmental factors and Type 1 diabetes." Diabetes/Metabolism Revs.

14 (1998): 31–67.14. Naik RG, and Palmer JP. "Preservation of beta-cell function in Type 1 diabetes." Diabetes Rev.7 (1999): 154–182.

15. Virtanen SM, Rasanen L, Aro A, et al. "Infant feeding in Finnish children less than 7 yr of age with newly diagnosed IDDM. Childhood diabetes in Finland Study Group." Diabetes Care 14(1991): 415–417.

16. Savilahti E, Akerblom HK, Tainio V-M, et al. "Children with newly diagnosed insulin dependent diabetes mellitus have increased levels of cow's milk antibodies." Diabetes Res. 7 (1988):137–140.

17. Yakota A, Yamaguchi T, Ueda T, et al. "Comparison of islet cell antibodies, islet cell surfactantibodies and anti-bovine serum albumin antibodies in Type 1 diabetes." Diabetes Res. Clin.Pract. 9 (1990): 211–217.

18. Hammond-McKibben D, and Dosch H-M. "Cow's milk, bovine serum albumin, and IDDM:can we settle the controversies?" Diabetes Care 20 (1997): 897–901.

19. Akerblom HK, Vaarala O, Hyoty H, et al. "Environmental factors in the etiology of Type 1diabetes." Am. J. Med. Genet. (Semin. Med. Genet.) 115 (2002): 18–29.

20. Gottlieb MS, and Root HF. "Diabetes mellitus in twins." Diabetes 17 (1968): 693–704.388 

21. Barnett AH, Eff C, Leslie RDG, et al. "Diabetes in identical twins: a study of 200 pairs." Diabetologia20 (1981): 87–93.

22. Borch-Johnsen K, Joner G, Mandrup-Poulsen T, et al. "Relation between breast feedingand incidence rates of insulin-dependent diabetes mellitus: a hypothesis." Lancet 2 (1984):1083–1086.

23. Perez-Bravo F, Carrasco E, Gutierrez-Lopez MD, et al. "Genetic predisposition and environmental factors leading to the development of insulin-dependent diabetes mellitus in Chilean children." J. Mol. Med. 74 (1996): 105–109.

24. Kostraba JN, Cruickshanks KJ, Lawler-Heavner J, et al. "Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM." Diabetes 42 (1993): 288–295.

25. Pyke DA. "The genetic perspective: putting research into practice." In: Diabetes 1988, Amsterdam,1989, pp. 1227–1230.

26. Kaprio J, Tuomilehto J, Koskenvuo M, et al. "Concordance for Type 1 (insulin-dependent)and Type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland." Diabetologia 35 (1992): 1060–1067.

27. Dahl-Jorgensen K, Joner G, and Hanssen KF. "Relationship between cow's milk consumption and incidence of IDDM in childhood." Diabetes Care 14 (1991): 1081–1083.

28. The proportion of Type 1 diabetes due to the consumption of cow's milk, the r2 value, is 96%.

29. LaPorte RE, Tajima N, Akerblom HK, et al. "Geographic differences in the risk of insulin dependent diabetes mellitus: the importance of registries." Diabetes Care 8(Suppl. 1) (1985):101–107.

30. Bodansky HJ, Staines A, Stephenson C, et al. "Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population." Brit. Med. Journ. 304(1992): 1020–1022.

31. Burden AC, Samanta A, and Chaunduri KH. "The prevalence and incidence of insulin-dependent diabetes in white and Indian children in Leicester city (UK)." Int. J. Diabetes Dev.Countries 10 (1990): 8–10.

32. Elliott R, and Ong TJ. "Nutritional genomics." Brit. Med. Journ. 324 (2002): 1438–1442.

33. Onkamo P, Vaananen S, Karvonen M, et al. "Worldwide increase in incidence of Type 1 diabetes—the analysis of the data on published incidence trends." Diabetologia 42 (1999):1395–1403.

34. Gerstein HC. "Cow's milk exposure and Type 1 diabetes mellitus: a critical overview of the clinical literature." Diabetes Care 17 (1994): 13–19.

35. Kimpimaki T, Erkkola M, Korhonen S, et al. "Short-term exclusive breastfeeding predisposes young children with increased genetic risk of Type 1 diabetes to progressive beta-cell autoimmunity." Diabetologia 44 (2001): 63–69.

36. Virtanen SM, Laara E, Hypponen E, et al. "Cow's milk consumption, HLA-DQB1 genotype,and Type 1 diabetes." Diabetes 49 (2000): 912–917.

37. Monetini L, Cavallo MG, Stefanini L, et al. "Bovine beta-casein antibodies in breast- and bottle-fed infants: their relevance in Type 1 diabetes." Diabetes Metab. Res. Rev. 17 (2001):51–54.

38. Norris JM, and Pietropaolo M. "Review article. Controversial topics series: milk proteins and diabetes." J. Endocrinol. Invest. 22 (1999): 568–580.

39. Reingold SC. "Research Directions in Multiple Sclerosis." National Multiple Sclerosis Society,November 25, 2003. Accessed at http://www.nationalmssociety.org/%5CBrochures-Research.asp

40. Ackermann A. "Die multiple sklerose in der Schweiz." Schweiz. med. Wchnschr. 61 (1931):1245–1250.

41. Swank RL. "Multiple sclerosis: correlation of its incidence with dietary fat." Am. J. Med. Sci.220 (1950): 421–430.

42. Dip JB. "The distribution of multiple sclerosis in relation to the dairy industry and milk consumption."New Zealand Med. J. 83 (1976): 427–430.

43. McDougall JM. 2002. Multiple sclerosis stopped by McDougall/Swank Program. www.nealhendrickson.com/McDougall/McDnewannouncementSwank021112.htm. Accessed Nov.16, 2002.

44. McLeod JG, Hammond SR, and Hallpike JF. "Epidemiology of multiple sclerosis in Australia.With NSW and SA survey results." Med. J. Austr 160 (1994): 117–122.

45. Lawrence JS, Behrend T, Bennett PH, et al. "Geographical studies of rheumatoid arthritis."Ann. Rheum. Dis. 25 (1966): 425–432.

46. Keen H, and Ekoe JM. "The geography of diabetes mellitus." Brit. Med. Journ. 40 (1984):359–365.

47. Swank RL. "Effect of low saturated fat diet in early and late cases of multiple sclerosis." Lancet336 (1990): 37–39.

48. Swank RL. "Treatment of multiple sclerosis with low fat diet." A.M.A. Arch. Neurol. Psychiatry69 (1953): 91–103.

49. Swank RL, and Bourdillon RB. "Multiple sclerosis: assessment of treatment with modified low fat diet." J. Nerv. Ment. Dis. 131 (1960): 468–488.

50. Swank RL. "Multiple sclerosis: twenty years on low fat diet." Arch. Neurol. 23 (1970): 460–474.

51. Agranoff BW, and Goldberg D. "Diet and the geographical distribution of multiple sclerosis."Lancet 2(7888) (November 2 1974): 1061–1066.

52. Malosse D, Perron H, Sasco A, et al. "Correlation between milk and dairy product consumption and multiple sclerosis prevalence: a worldwide study." Neuroepidemiology 11 (1992):304–312.

53. Malosse D, and Perron H. "Correlation analysis between bovine populations, other farm animals,house pets, and multiple sclerosis prevalence." Neuroepidemiology 12 (1993): 15–27.

54. Lauer K. "Diet and multiple sclerosis." Neurology 49(suppl 2) (1997): S55–S61.

55. Swank RL, Lerstad O, Strom A, et al. "Multiple sclerosis in rural Norway. Its geographic distribution and occupational incidence in relation to nutrition." New Engl. J. Med. 246 (1952):721–728.

56. Dalgleish AG. "Viruses and multiple sclerosis." Acta Neurol. Scand. Suppl. 169 (1997): 8–15.

57. McAlpine D, Lumsden CE, and Acheson ED. Multiple sclerosis: a reappraisal. Edinburgh and London: E&S Livingston, 1965.

58. Alter M, Liebowitz U, and Speer J. "Risk of multiple sclerosis related to age at immigration to Israel." Arch. Neurol. 15 (1966): 234–237.

59. Kurtzke JF, Beebe GW, and Norman JE, Jr. "Epidemiology of multiple sclerosis in U.S. veterans:1. Race, sex, and geographic distribution." Neurology 29 (1979): 1228–1235.

60. Ebers GC, Bulman DE, Sadovnick AD, et al. "A population-based study of multiple sclerosis in twins." New Engl. J. Med. 315 (1986): 1638–1642.

61. Acheson ED, Bachrach CA, and Wright FM. "Some comments on the relationship of the distribution of multiple sclerosis to latitude solar radiation and other variables." Acta PsychiatricaNeurologica Scand. 35 (Suppl.147) (1960): 132–147.

62. Warren S, and Warren KG. "Multiple sclerosis and associated diseases: a relationship to diabetes mellitus." J. Canadian Sci. Neurol. 8 (1981): 35–39.

63. Wertman E, Zilber N, and Abransky O. "An association between multiple sclerosis and Type1 diabetes mellitus." J. Neurol. 239 (1992): 43–45.

64. Marrosu MG, Cocco E, Lai M, et al. "Patients with multiple sclerosis and risk of Type 1 diabetesmellitus in Sardinia, Italy: a cohort study." Lancet 359 (2002): 1461–1465.

65. Buzzetti R, Pozzilli P, Di Mario U, et al. "Multiple sclerosis and Type 1 diabetes." Diabetologia45 (2002): 1735–1736.

66. Lux WE, and Kurtzke JF. "Is Parkinson's disease acquired? Evidence from a geographic comparison with multiple sclerosis." Neurology 37 (1987): 467–471.

67. Prahalad S, Shear ES, Thompson SD, et al. "Increased Prevalence of Familial Autoimmunity in Simplex and Multiplex Families with Juvenile Rheumatoid Arthritis." Arthritis Rheumatism46 (2002): 1851–1856.

68. Cantorna MT, Munsick C, Bemiss C, et al. "1,25-Dihydroxycholecalciferol Prevents and Ameliorates Symptoms of Experimental Murine Inflammatory Bowel Disease." J. Nutr. 130(2000): 2648–2652.

69. Cantorna MT, Woodward WD, Hayes CE, et al. "1,25-Dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-B1 and IL-4." J Immunol. 160 (1998):5314–5319.

70. Cantorna MT, Humpal-Winter J, and DeLuca HF. "Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice." J. Nutr. 129 (1999): 1966–1971.

71. Multiple Sclerosis International Federation. "Alternative Therapies." November 25,2003. Accessed at www.msif.org/en/symptoms_treatments/treatment_overview/alternative.html